Serge Saxonov

Oakland, CA, United States of America

Serge Saxonov

This inventor holds 107 USPTO granted patents and 78 published patent applications, plus 3 CIPO patents and 29 EPO patents, primarily in Nucleic Acid Analysis (CPC class C12Q1-6806). Top assignees: 10X Genomics, Inc., 23Andme, Inc., Bio-Rad Laboratories, Inc.. Active years: 2013-2025.

USPTO Granted Patents = 107 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.7

ph-index = 42

Forward Citations = 6,432(Granted Patents)

Forward Citations (Not Self Cited) = 4,410(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • San Mateo, CA (US) (2013 - 2015)
  • Seattle, CA (US) (2019)
  • Seattle, WA (US) (2013 - 2020)
  • Oakland, CA (US) (2014 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acid Analysis
Sequencing Methods
Genetic Comparisons
Inherited Segments
Polynucleotide Processing
Fluidic Devices
Capsule Array Devices
Sample Processing
Targeted Sequencing
Finding Relatives
107 patents (USPTO):Explore Patents

Title: The Innovative Journey of Serge Saxonov

Introduction: Serge Saxonov, a pioneering inventor based in Oakland, CA, has made significant contributions to the field of biotechnology with his groundbreaking innovations.

Latest Patents: Serge Saxonov holds several patents in the biotech industry, including inventions related to genetic sequencing technologies, diagnostic tools, and personalized medicine advancements.

Career Highlights: With a background in molecular biology and bioinformatics, Serge Saxonov co-founded a leading biotech company that focuses on developing cutting-edge solutions for genetic analysis and precision medicine. His work has revolutionized the way genetic information is utilized in healthcare.

Collaborations: Throughout his career, Serge Saxonov has collaborated with top researchers, scientists, and medical professionals to further the impact of his inventions. His collaborative efforts have led to the development of innovative technologies that have the potential to improve patient outcomes and advance the field of biotechnology.

Conclusion: Serge Saxonov's dedication to innovation and his relentless pursuit of scientific excellence have solidified his reputation as a visionary inventor in the biotech industry. His contributions continue to shape the future of personalized medicine and genetic research, making him a key figure in the world of biotechnological advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…